Conrad Gorinsky

Dr. Conrad Gorinsky is a Guyana-born chemist who studied in the UK. He spent months with the Amazonian Wapishana tribe and later obtained US patents for tipir and cunani, two chemicals derived from plants used by the tribe. In 1968 he travelled on a BBC-funded expedition in the Amazon with the explorer Robin Hanbury-Tenison, having a discussion with him that led to the foundation of Survival International.[1]

Patent controversy

Further information: bioprospecting

Rupununine

Gorinsky patented tipir as rupununine (after the nearby Rupununi river), which is an antipyretic derived from the Greenheart tree. His patent claims it may be used to treat malaria and cancer.

The Wapishana tribe grind this nut and use it to stop bleeding and as an abortifacient which provokes miscarriage. They wanted the patent rescinded, but Gorinsky replied:

"Tough, isn't it?", he says. "I was not the only person looking at the greenheart. I just picked up a nut and said 'what can I do with this?'. I have analysed the chemical structure but I have not patented the tree or a life process. How can I tell the Wapishana about the science? They just inherited the greenheart. They don't own it. I have invested in this with my own money".[2]

Cunaniol

Gorinsky was one of several who isolated a potent chemical from certain plants that the tribe used for fishing. The natives called the plant cunani, after which Gorinsky called the chemical "cuaniol". Being a potent neurotoxin, fish in the surrounding area become disoriented and could easily be caught. Gorinsky patented the use of cunaniol for the treatment of heart disease. The chemical, also known as ichthyothereol, is a potent toxin.

Footnotes

  1. ↑ Hanbury-Tenison, Robin (1991). Worlds Apart: An Explorer's Life. Arrow Books. pp. 115–128.
  2. ↑ Patenting life, Biopirates who seek the greatest prizes, John Vidal, The Guardian, Wednesday 15 November 2000

External links

This article is issued from Wikipedia - version of the Saturday, March 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.